During the last session, Vistagen Therapeutics Inc (NASDAQ:VTGN)’s traded shares were 0.5 million, with the beta value of the company hitting 0.77. At the end
Vistagen Therapeutics Inc (NASDAQ:VTGN)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting 0.79. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
